CA2354194A1 - Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells - Google Patents

Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells Download PDF

Info

Publication number
CA2354194A1
CA2354194A1 CA002354194A CA2354194A CA2354194A1 CA 2354194 A1 CA2354194 A1 CA 2354194A1 CA 002354194 A CA002354194 A CA 002354194A CA 2354194 A CA2354194 A CA 2354194A CA 2354194 A1 CA2354194 A1 CA 2354194A1
Authority
CA
Canada
Prior art keywords
cells
growth hormone
vivo
donor
regenerating hematopoiesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002354194A
Other languages
English (en)
French (fr)
Inventor
Alessandro Massimo Gianni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Serono SA
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2354194A1 publication Critical patent/CA2354194A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002354194A 1998-12-30 1999-12-30 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells Abandoned CA2354194A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98124834A EP1016413A1 (en) 1998-12-30 1998-12-30 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
EP98124834.7 1998-12-30
PCT/EP1999/010470 WO2000040260A1 (en) 1998-12-30 1999-12-30 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells

Publications (1)

Publication Number Publication Date
CA2354194A1 true CA2354194A1 (en) 2000-07-13

Family

ID=8233268

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002354194A Abandoned CA2354194A1 (en) 1998-12-30 1999-12-30 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells

Country Status (15)

Country Link
US (1) US20060029581A1 (cg-RX-API-DMAC7.html)
EP (3) EP1016413A1 (cg-RX-API-DMAC7.html)
JP (1) JP4808316B2 (cg-RX-API-DMAC7.html)
AT (1) ATE342064T1 (cg-RX-API-DMAC7.html)
AU (2) AU772222B2 (cg-RX-API-DMAC7.html)
BR (1) BR9916726A (cg-RX-API-DMAC7.html)
CA (1) CA2354194A1 (cg-RX-API-DMAC7.html)
CY (1) CY1107603T1 (cg-RX-API-DMAC7.html)
DE (1) DE69933581T2 (cg-RX-API-DMAC7.html)
DK (1) DK1140149T3 (cg-RX-API-DMAC7.html)
ES (1) ES2275359T3 (cg-RX-API-DMAC7.html)
IL (2) IL143994A0 (cg-RX-API-DMAC7.html)
PT (1) PT1140149E (cg-RX-API-DMAC7.html)
SI (1) SI1140149T1 (cg-RX-API-DMAC7.html)
WO (1) WO2000040260A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60140051D1 (de) * 2000-06-07 2009-11-12 Merck Serono Sa Coinsins Menschliches wachstumshormon zur stimulierung der mobilisierung pluripotenter hämapoietischer stammzellen
JP2004504834A (ja) 2000-08-01 2004-02-19 イスム リサーチ ディベロップメント カンパニー 胚性細胞の定方向分化
CN102302493B (zh) 2001-07-31 2015-08-12 健赞股份有限公司 活化祖细胞/干细胞的方法
WO2005032572A2 (en) 2003-10-03 2005-04-14 Vib Vzw Means and methods for the recruitment and identification of stem cells
JP2005289837A (ja) * 2004-03-31 2005-10-20 Juntendo 骨髄細胞誘導剤の製造方法及び製造装置
BRPI0519170A8 (pt) * 2004-12-22 2018-05-08 Ambrx Inc formulações de hormônio de crescimento humano que compreendem um aminoácido não naturalmente codificado
JP2013515081A (ja) * 2009-12-21 2013-05-02 アンブルックス,インコーポレイテッド 修飾されているブタのソマトトロピンポリペプチドおよびそれらの使用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5649904A (en) * 1988-10-07 1997-07-22 Sandoz Ltd. Method of treating cancer with a fully myeloablative regimen of chemotherapy, radiation or both
US5199942A (en) * 1991-06-07 1993-04-06 Immunex Corporation Method for improving autologous transplantation
EP0563485A1 (en) * 1992-03-30 1993-10-06 Schering-Plough In vitro generation of human dendritic cells and uses thereof
JPH08511263A (ja) * 1993-06-15 1996-11-26 ブリテッシュ バイオテック ファーマシューティカルズ リミテッド 造血細胞の放出と可動化
JPH07101877A (ja) * 1993-10-04 1995-04-18 Mitsui Toatsu Chem Inc 血小板減少症治療剤
DE69433967D1 (de) * 1993-10-06 2004-09-30 Univ Florida Stammzellen-proliferations-faktor
JPH0892001A (ja) * 1994-09-26 1996-04-09 Asahi Medical Co Ltd 細胞集団の保存方法
CA2227241C (en) * 1995-07-21 2004-12-21 THE GOVERNMENT OF THE UNITED STATES, represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment
WO1997026326A1 (en) * 1996-01-16 1997-07-24 Depuy Orthopaedics, Inc. Isolation of precursor cells from hematopoietic and non-hematopoietic tissues and their use
JP4042925B2 (ja) * 1996-11-20 2008-02-06 シスメックス株式会社 幼若白血球の分類計数法
JPH10295369A (ja) * 1997-02-26 1998-11-10 Japan Tobacco Inc 造血幹細胞の製造方法
SE9804064D0 (sv) * 1998-11-25 1998-11-25 A & Science Invest Ab Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells
EP1016414B1 (en) * 1998-12-17 2004-09-08 Applied Research Systems ARS Holding N.V. Human growth hormone to stimulate hematopoiesis and immune reconstitution after hematopoietic stem cell transplantation in humans
DE60140051D1 (de) * 2000-06-07 2009-11-12 Merck Serono Sa Coinsins Menschliches wachstumshormon zur stimulierung der mobilisierung pluripotenter hämapoietischer stammzellen
US7220407B2 (en) * 2003-10-27 2007-05-22 Amgen Inc. G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction

Also Published As

Publication number Publication date
EP1779865A1 (en) 2007-05-02
CY1107603T1 (el) 2013-03-13
IL143994A (en) 2009-06-15
DE69933581D1 (de) 2006-11-23
AU2103900A (en) 2000-07-24
EP1140149A1 (en) 2001-10-10
BR9916726A (pt) 2001-09-11
WO2000040260A1 (en) 2000-07-13
SI1140149T1 (sl) 2007-02-28
DK1140149T3 (da) 2007-02-19
JP4808316B2 (ja) 2011-11-02
AU772222B2 (en) 2004-04-22
US20060029581A1 (en) 2006-02-09
DE69933581T2 (de) 2007-06-21
AU2004203355B2 (en) 2007-05-17
AU2004203355A1 (en) 2004-08-19
JP2002534393A (ja) 2002-10-15
PT1140149E (pt) 2007-01-31
IL143994A0 (en) 2002-04-21
ES2275359T3 (es) 2007-06-01
EP1016413A1 (en) 2000-07-05
ATE342064T1 (de) 2006-11-15
EP1140149B1 (en) 2006-10-11

Similar Documents

Publication Publication Date Title
EP1286689B1 (en) Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
AU2001281800A1 (en) Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
US6013067A (en) Methods for increasing hematopoietic cells
EP0289186A2 (en) Process for increasing the growth rate and enhancing the feed efficiency of meat producing livestock
JP2005336202A (ja) マクロファージ炎症蛋白変種
EP1140149B1 (en) Use of human growth hormone to increase the number of circulating cd34+ cells, intended for reconstitution of the hematopoietic and immune systems following myeloablative or antiblastic therapies, by transplantation, re-infusion or engraftment
Weaver et al. Randomized comparison of progenitor-cell mobilization using chemotherapy, stem-cell factor, and filgrastim or chemotherapy plus filgrastim alone in patients with ovarian cancer.
WO1997015595A1 (en) Method of mobilizing hematopoietic stem cells
EP1165118B1 (en) Treatment of multiple sclerosis with a combination of interferon and growth hormone
US6348444B1 (en) Human growth hormone to stimulate hematopoiesis and immune reconstitution after hematopoietic stem cell transplantation in humans
MXPA01006681A (en) Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
JPH08127539A (ja) ヒトil−11を含有する末梢血幹細胞増加剤
EP1033997B1 (en) Method of mobilizing hematopoietic stem cells
van Miere et al. The effects of ACTH, prednisolone and Escherichia coli endotoxin on some clinical haematological and blood biochemical parameters in dwarf goats
Finley Overview of Biotechnology in Health Care
Simone Supportive care-Present use of biologicals in supportive care
MXPA98003217A (en) Method of mobilization of hematopoyetic mother cells

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued